Vespa crabro chromosome 7, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342406.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
beta-1,4-glucuronyltransferase 1-like, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
beta-1,4-glucuronyltransferase 1-like, transcript variant X1
beta-1,4-glucuronyltransferase 1-like isoform X2
beta-1,4-glucuronyltransferase 1-like isoform X1
potassium channel subfamily K member 10-like, transcript variant X1
potassium channel subfamily K member 10-like, transcript variant X2
uncharacterized protein LOC124425712 isoform X1
potassium channel subfamily K member 10-like isoform X2
protein tumorous imaginal discs, mitochondrial, transcript variant X2
protein tumorous imaginal discs, mitochondrial, transcript variant X1
protein tumorous imaginal discs, mitochondrial isoform X2
protein tumorous imaginal discs, mitochondrial isoform X1
protein tumorous imaginal discs, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein tumorous imaginal discs, mitochondrial, transcript variant X4
protein tumorous imaginal discs, mitochondrial isoform X3
ceramide phosphoethanolamine synthase, transcript variant X2
ceramide phosphoethanolamine synthase, transcript variant X1
SET domain-containing protein SmydA-8-like
uncharacterized LOC124425709, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124425709, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124425709, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124425709, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124425709, transcript variant X1
uncharacterized LOC124425709, transcript variant X3
programmed cell death protein 6, transcript variant X1
programmed cell death protein 6, transcript variant X2
programmed cell death protein 6 isoform X2
programmed cell death protein 6 isoform X1
dolichyl-phosphate beta-glucosyltransferase, transcript variant X1
dolichyl-phosphate beta-glucosyltransferase, transcript variant X2
dolichyl-phosphate beta-glucosyltransferase isoform X2
dolichyl-phosphate beta-glucosyltransferase isoform X1
integrin-linked protein kinase homolog pat-4, transcript variant X1
integrin-linked protein kinase homolog pat-4, transcript variant X3
integrin-linked protein kinase homolog pat-4, transcript variant X2
integrin-linked protein kinase homolog pat-4 isoform X1
integrin-linked protein kinase homolog pat-4 isoform X2
integrin-linked protein kinase homolog pat-4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124425741, transcript variant X4
uncharacterized LOC124425741, transcript variant X3
uncharacterized LOC124425741, transcript variant X2
uncharacterized LOC124425741, transcript variant X1
uncharacterized LOC124425741, transcript variant X5
uncharacterized LOC124425741, transcript variant X6
uncharacterized protein LOC124425741 isoform X2
uncharacterized protein LOC124425741 isoform X1
uncharacterized protein LOC124425741 isoform X3
spindle pole body component 110-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spindle pole body component 110-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
spindle pole body component 110-like, transcript variant X1
lethal(3)malignant brain tumor-like protein 3, transcript variant X1
lethal(3)malignant brain tumor-like protein 3, transcript variant X3
lethal(3)malignant brain tumor-like protein 3, transcript variant X2
lethal(3)malignant brain tumor-like protein 3, transcript variant X5
lethal(3)malignant brain tumor-like protein 3, transcript variant X4
lethal(3)malignant brain tumor-like protein 3 isoform X1
lethal(3)malignant brain tumor-like protein 3 isoform X2
lethal(3)malignant brain tumor-like protein 3 isoform X3
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X3
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X1
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like
uncharacterized LOC124425738, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124425738, transcript variant X2
uncharacterized LOC124425738, transcript variant X1
uncharacterized LOC124425738, transcript variant X3
uncharacterized protein LOC124425738 isoform X1
uncharacterized protein LOC124425738 isoform X2
uncharacterized protein LOC124425738 isoform X4
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC124425738, transcript variant X4
uncharacterized LOC124425738, transcript variant X5
electron transfer flavoprotein beta subunit lysine methyltransferase-like isoform X2
uncharacterized protein LOC124425738 isoform X3
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X1
electron transfer flavoprotein beta subunit lysine methyltransferase-like isoform X1
nuclear receptor-binding protein homolog, transcript variant X1
nuclear receptor-binding protein homolog, transcript variant X2
nuclear receptor-binding protein homolog isoform X1
nuclear receptor-binding protein homolog isoform X2
phospholipase A2 group XV-like, transcript variant X1
phospholipase A2 group XV-like, transcript variant X2
phospholipase A2 group XV-like isoform X2
phospholipase A2 group XV-like isoform X1
secretion-regulating guanine nucleotide exchange factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
secretion-regulating guanine nucleotide exchange factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
secretion-regulating guanine nucleotide exchange factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
secretion-regulating guanine nucleotide exchange factor isoform X3
secretion-regulating guanine nucleotide exchange factor isoform X1
secretion-regulating guanine nucleotide exchange factor isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
elongation factor Ts, mitochondrial, transcript variant X1
elongation factor Ts, mitochondrial, transcript variant X3
elongation factor Ts, mitochondrial, transcript variant X2
elongation factor Ts, mitochondrial isoform X1
elongation factor Ts, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
class E basic helix-loop-helix protein 23, transcript variant X2
class E basic helix-loop-helix protein 23, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
class E basic helix-loop-helix protein 23, transcript variant X1
class E basic helix-loop-helix protein 23 isoform X1
class E basic helix-loop-helix protein 23 isoform X2
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X1
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X2
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial isoform X1
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X3
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial isoform X2
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial isoform X3
glyceraldehyde-3-phosphate dehydrogenase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
glyceraldehyde-3-phosphate dehydrogenase 2-like
ralBP1-associated Eps domain-containing protein 1
protein lethal(2)essential for life-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
baculoviral IAP repeat-containing protein 3-like, transcript variant X1
baculoviral IAP repeat-containing protein 3-like, transcript variant X2
baculoviral IAP repeat-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X2
cell division cycle protein 23 homolog, transcript variant X3
cell division cycle protein 23 homolog, transcript variant X1
cell division cycle protein 23 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cell division cycle protein 23 homolog isoform X3
cell division cycle protein 23 homolog isoform X1
cell division cycle protein 23 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
protein Wnt-6-like, transcript variant X3
neither inactivation nor afterpotential protein C, transcript variant X6
neither inactivation nor afterpotential protein C, transcript variant X3
neither inactivation nor afterpotential protein C, transcript variant X4
neither inactivation nor afterpotential protein C, transcript variant X1
neither inactivation nor afterpotential protein C, transcript variant X5
neither inactivation nor afterpotential protein C, transcript variant X2
neither inactivation nor afterpotential protein C, transcript variant X12
neither inactivation nor afterpotential protein C isoform X2
neither inactivation nor afterpotential protein C isoform X1
neither inactivation nor afterpotential protein C isoform X5
neither inactivation nor afterpotential protein C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
neither inactivation nor afterpotential protein C, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neither inactivation nor afterpotential protein C, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
neither inactivation nor afterpotential protein C, transcript variant X11
neither inactivation nor afterpotential protein C, transcript variant X9
neither inactivation nor afterpotential protein C isoform X3
neither inactivation nor afterpotential protein C isoform X4
neither inactivation nor afterpotential protein C, transcript variant X13
neither inactivation nor afterpotential protein C isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein Wnt-6-like, transcript variant X2
protein Wnt-6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 711 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 738 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sodium bicarbonate cotransporter 3, transcript variant X4
sodium bicarbonate cotransporter 3, transcript variant X15
sodium bicarbonate cotransporter 3, transcript variant X1
sodium bicarbonate cotransporter 3, transcript variant X14
sodium bicarbonate cotransporter 3, transcript variant X19
sodium bicarbonate cotransporter 3, transcript variant X17
sodium bicarbonate cotransporter 3, transcript variant X20
sodium bicarbonate cotransporter 3, transcript variant X16
sodium bicarbonate cotransporter 3, transcript variant X2
sodium bicarbonate cotransporter 3, transcript variant X12
sodium bicarbonate cotransporter 3, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sodium bicarbonate cotransporter 3, transcript variant X21
sodium bicarbonate cotransporter 3, transcript variant X23
sodium bicarbonate cotransporter 3, transcript variant X8
sodium bicarbonate cotransporter 3, transcript variant X6
sodium bicarbonate cotransporter 3, transcript variant X10
sodium bicarbonate cotransporter 3, transcript variant X11
sodium bicarbonate cotransporter 3, transcript variant X7
sodium bicarbonate cotransporter 3, transcript variant X5
sodium bicarbonate cotransporter 3, transcript variant X9
electroneutral sodium bicarbonate exchanger 1 isoform X2
sodium bicarbonate cotransporter 3, transcript variant X3
electroneutral sodium bicarbonate exchanger 1 isoform X1
electroneutral sodium bicarbonate exchanger 1 isoform X4
sodium bicarbonate cotransporter 3 isoform X8
sodium bicarbonate cotransporter 3 isoform X6
electroneutral sodium bicarbonate exchanger 1 isoform X9
electroneutral sodium bicarbonate exchanger 1 isoform X5
electroneutral sodium bicarbonate exchanger 1 isoform X7
electroneutral sodium bicarbonate exchanger 1 isoform X10
electroneutral sodium bicarbonate exchanger 1 isoform X12
sodium bicarbonate cotransporter 3, transcript variant X13
electroneutral sodium bicarbonate exchanger 1 isoform X3
sodium bicarbonate cotransporter 3, transcript variant X22
electroneutral sodium bicarbonate exchanger 1 isoform X11
hepatoma-derived growth factor-related protein 2
bone morphogenetic protein receptor type-2, transcript variant X2
bone morphogenetic protein receptor type-2, transcript variant X1
bone morphogenetic protein receptor type-2 isoform X2
bone morphogenetic protein receptor type-2 isoform X1
43 kDa receptor-associated protein of the synapse homolog, transcript variant X1
43 kDa receptor-associated protein of the synapse homolog, transcript variant X6
43 kDa receptor-associated protein of the synapse homolog, transcript variant X2
43 kDa receptor-associated protein of the synapse homolog, transcript variant X3
43 kDa receptor-associated protein of the synapse homolog, transcript variant X5
43 kDa receptor-associated protein of the synapse homolog, transcript variant X4
43 kDa receptor-associated protein of the synapse homolog isoform X5
43 kDa receptor-associated protein of the synapse homolog isoform X3
43 kDa receptor-associated protein of the synapse homolog isoform X6
43 kDa receptor-associated protein of the synapse homolog isoform X2
43 kDa receptor-associated protein of the synapse homolog isoform X1
43 kDa receptor-associated protein of the synapse homolog isoform X4
transcription factor SUM-1, transcript variant X1
transcription factor SUM-1, transcript variant X4
transcription factor SUM-1, transcript variant X3
transcription factor SUM-1, transcript variant X7
transcription factor SUM-1, transcript variant X6
transcription factor SUM-1, transcript variant X5
transcription factor SUM-1, transcript variant X2
afadin- and alpha-actinin-binding protein-like, transcript variant X2
afadin- and alpha-actinin-binding protein-like, transcript variant X1
afadin- and alpha-actinin-binding protein-like isoform X1
afadin- and alpha-actinin-binding protein-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124425426, transcript variant X2
uncharacterized LOC124425426, transcript variant X3
uncharacterized LOC124425426, transcript variant X1
dynein axonemal intermediate chain 7 homolog
cytochrome b-c1 complex subunit Rieske, mitochondrial-like, transcript variant X1
cytochrome b-c1 complex subunit Rieske, mitochondrial-like, transcript variant X2
cytochrome b-c1 complex subunit Rieske, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cytochrome b-c1 complex subunit Rieske, mitochondrial-like isoform X1
cytochrome b-c1 complex subunit Rieske, mitochondrial-like isoform X2
cytochrome b-c1 complex subunit Rieske, mitochondrial-like isoform X3
mediator of RNA polymerase II transcription subunit 11-like
rho guanine nucleotide exchange factor 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
rho guanine nucleotide exchange factor 7
rho guanine nucleotide exchange factor 7, transcript variant X1
rho guanine nucleotide exchange factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
macro domain-containing protein CT2219-like, transcript variant X2
macro domain-containing protein CT2219-like, transcript variant X1
macro domain-containing protein CT2219-like isoform X1
macro domain-containing protein CT2219-like isoform X2
serine/threonine-protein kinase MARK2-like, transcript variant X19
serine/threonine-protein kinase MARK2-like, transcript variant X20
serine/threonine-protein kinase MARK2-like, transcript variant X10
serine/threonine-protein kinase MARK2-like, transcript variant X14
serine/threonine-protein kinase MARK2-like, transcript variant X7
serine/threonine-protein kinase MARK2-like, transcript variant X17
serine/threonine-protein kinase MARK2-like, transcript variant X18
serine/threonine-protein kinase MARK2-like, transcript variant X1
serine/threonine-protein kinase MARK2-like, transcript variant X13
serine/threonine-protein kinase MARK2-like, transcript variant X16
serine/threonine-protein kinase MARK2-like, transcript variant X9
serine/threonine-protein kinase MARK2-like, transcript variant X12
serine/threonine-protein kinase MARK2-like, transcript variant X6
serine/threonine-protein kinase MARK2-like, transcript variant X15
serine/threonine-protein kinase MARK2-like, transcript variant X8
serine/threonine-protein kinase MARK2-like, transcript variant X11
serine/threonine-protein kinase MARK2-like, transcript variant X21
serine/threonine-protein kinase MARK2-like isoform X17
serine/threonine-protein kinase MARK2-like, transcript variant X4
serine/threonine-protein kinase MARK2-like, transcript variant X2
serine/threonine-protein kinase MARK2-like, transcript variant X5
serine/threonine-protein kinase MARK2-like, transcript variant X3
serine/threonine-protein kinase MARK2-like isoform X1
serine/threonine-protein kinase MARK2-like isoform X9
serine/threonine-protein kinase MARK2-like isoform X6
serine/threonine-protein kinase MARK2-like isoform X10
serine/threonine-protein kinase MARK2-like isoform X2
serine/threonine-protein kinase MARK2-like isoform X11
serine/threonine-protein kinase MARK2-like isoform X12
serine/threonine-protein kinase MARK2-like isoform X5
serine/threonine-protein kinase MARK2-like isoform X3
serine/threonine-protein kinase MARK2-like isoform X4
serine/threonine-protein kinase MARK2-like isoform X7
serine/threonine-protein kinase MARK2-like isoform X8
serine/threonine-protein kinase MARK2-like isoform X13
serine/threonine-protein kinase MARK2-like isoform X15
serine/threonine-protein kinase MARK2-like isoform X14
serine/threonine-protein kinase MARK2-like isoform X16
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]
putative elongator complex protein 1, transcript variant X1
putative elongator complex protein 1 isoform X1
putative elongator complex protein 1, transcript variant X2
vacuolar protein sorting-associated protein 26C
protein mono-ADP-ribosyltransferase PARP16
protein-serine O-palmitoleoyltransferase porcupine
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mitochondrial proton/calcium exchanger protein
vacuolar protein sorting-associated protein 13B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124425461, transcript variant X1
uncharacterized LOC124425461, transcript variant X2
uncharacterized protein LOC124425461 isoform X2
uncharacterized protein LOC124425461 isoform X1
rho-related BTB domain-containing protein 1, transcript variant X5
rho-related BTB domain-containing protein 1, transcript variant X10
rho-related BTB domain-containing protein 1, transcript variant X3
rho-related BTB domain-containing protein 1, transcript variant X1
rho-related BTB domain-containing protein 1, transcript variant X11
rho-related BTB domain-containing protein 1, transcript variant X2
rho-related BTB domain-containing protein 1, transcript variant X4
rho-related BTB domain-containing protein 1, transcript variant X6
rho-related BTB domain-containing protein 1, transcript variant X9
rho-related BTB domain-containing protein 1, transcript variant X7
rho-related BTB domain-containing protein 1, transcript variant X8
rho-related BTB domain-containing protein 1 isoform X1
rho-related BTB domain-containing protein 1 isoform X2
H/ACA ribonucleoprotein complex subunit 2-like protein
poly [ADP-ribose] polymerase tankyrase, transcript variant X3
poly [ADP-ribose] polymerase tankyrase, transcript variant X1
poly [ADP-ribose] polymerase tankyrase, transcript variant X2
protein phosphatase 1 regulatory subunit 3B, transcript variant X1
protein phosphatase 1 regulatory subunit 3B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3B, transcript variant X2
protein phosphatase 1 regulatory subunit 3C isoform X1
protein phosphatase 1 regulatory subunit 3B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124425421, transcript variant X1
uncharacterized LOC124425421, transcript variant X2
interleukin enhancer-binding factor 2, transcript variant X1
interleukin enhancer-binding factor 2, transcript variant X2
interleukin enhancer-binding factor 2, transcript variant X3
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel trpm, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X6
transient receptor potential cation channel trpm, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X3
transient receptor potential cation channel trpm, transcript variant X5
transient receptor potential cation channel trpm, transcript variant X7
transient receptor potential cation channel trpm, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X4
transient receptor potential cation channel trpm, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transient receptor potential cation channel trpm isoform X5
transient receptor potential cation channel trpm isoform X6
transient receptor potential cation channel trpm isoform X2
transient receptor potential cation channel trpm isoform X7
transient receptor potential cation channel trpm isoform X3
transient receptor potential cation channel trpm isoform X4
transient receptor potential cation channel trpm isoform X1
transient receptor potential cation channel trpm isoform X9
transient receptor potential cation channel trpm isoform X8
leucine-rich repeat and calponin homology domain-containing protein, transcript variant X1
leucine-rich repeat and calponin homology domain-containing protein, transcript variant X3
leucine-rich repeat and calponin homology domain-containing protein, transcript variant X2
leucine-rich repeat and calponin homology domain-containing protein isoform X2
leucine-rich repeat and calponin homology domain-containing protein isoform X1
homeobox protein aristaless-like, transcript variant X2
homeobox protein aristaless-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mothers against decapentaplegic homolog 2, transcript variant X1
mothers against decapentaplegic homolog 2, transcript variant X2
mothers against decapentaplegic homolog 2 isoform X1
mothers against decapentaplegic homolog 2 isoform X2
protein IWS1 homolog, transcript variant X1
protein IWS1 homolog, transcript variant X2
putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable U3 small nucleolar RNA-associated protein 11
calcium-binding protein P-like, transcript variant X1
calcium-binding protein P-like, transcript variant X2
calcium-binding protein P-like isoform X2
calcium-binding protein P-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124425315 isoform X2
probable serine/threonine-protein kinase cdc7, transcript variant X1
probable serine/threonine-protein kinase cdc7, transcript variant X2
probable serine/threonine-protein kinase cdc7, transcript variant X3
probable serine/threonine-protein kinase cdc7
uncharacterized LOC124425314, transcript variant X1
uncharacterized LOC124425314, transcript variant X2
glutamate receptor 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor 3-like, transcript variant X1
uncharacterized protein LOC124425445 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor 1-like, transcript variant X3
glutamate receptor 1-like, transcript variant X1
glutamate receptor ionotropic, delta-2-like isoform X2
glutamate receptor ionotropic, delta-2-like isoform X1
glutamate receptor ionotropic, delta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124425497, transcript variant X4
uncharacterized LOC124425497, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC124425497 isoform X2
uncharacterized LOC124425497, transcript variant X2
uncharacterized LOC124425497, transcript variant X1
uncharacterized protein LOC124425497 isoform X1
ring canal kelch homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ring canal kelch homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ring canal kelch homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ring canal kelch homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124425514, transcript variant X1
uncharacterized LOC124425514, transcript variant X2
uncharacterized LOC124425514, transcript variant X3
uncharacterized LOC124425514, transcript variant X4
uncharacterized LOC124425514, transcript variant X5
uncharacterized LOC124425514, transcript variant X6
uncharacterized LOC124425514, transcript variant X7
uncharacterized LOC124425514, transcript variant X8
uncharacterized LOC124425514, transcript variant X9
uncharacterized protein LOC124425514 isoform X1
uncharacterized protein LOC124425514 isoform X2
uncharacterized protein LOC124425514 isoform X4
uncharacterized protein LOC124425514 isoform X3
uncharacterized LOC124425514, transcript variant X10
uncharacterized LOC124425514, transcript variant X13
uncharacterized LOC124425514, transcript variant X12
uncharacterized LOC124425514, transcript variant X11
uncharacterized protein LOC124425514 isoform X5
uncharacterized protein LOC124425514 isoform X7
uncharacterized protein LOC124425514 isoform X6
translocon-associated protein subunit gamma
troponin C, isoallergen Bla g 6.0301, transcript variant X1
troponin C, isoallergen Bla g 6.0301, transcript variant X2
troponin C, isoallergen Bla g 6.0301 isoform X1
troponin C, isoallergen Bla g 6.0301 isoform X2
NCK-interacting protein with SH3 domain, transcript variant X3
NCK-interacting protein with SH3 domain, transcript variant X2
NCK-interacting protein with SH3 domain, transcript variant X1
NCK-interacting protein with SH3 domain isoform X2
NCK-interacting protein with SH3 domain isoform X1
transcription initiation factor TFIID subunit 5, transcript variant X1
transcription initiation factor TFIID subunit 5 isoform X1
transcription initiation factor TFIID subunit 5, transcript variant X2
transcription initiation factor TFIID subunit 5 isoform X2
zinc finger protein 836-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 836-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger protein 836-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 836-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 836-like, transcript variant X5
uncharacterized LOC124425323, transcript variant X6
uncharacterized LOC124425323, transcript variant X5
uncharacterized LOC124425323, transcript variant X3
uncharacterized LOC124425323, transcript variant X2
uncharacterized LOC124425323, transcript variant X4
uncharacterized LOC124425323, transcript variant X7
uncharacterized LOC124425323, transcript variant X1
uncharacterized LOC124425323, transcript variant X8
uncharacterized protein LOC124425323 isoform X3
uncharacterized protein LOC124425323 isoform X2
uncharacterized protein LOC124425323 isoform X1
uncharacterized protein LOC124425323 isoform X4
hippocampus abundant transcript 1 protein, transcript variant X2
hippocampus abundant transcript 1 protein isoform X2
hippocampus abundant transcript 1 protein, transcript variant X1
hippocampus abundant transcript 1 protein, transcript variant X3
hippocampus abundant transcript 1 protein isoform X1
hippocampus abundant transcript 1 protein isoform X3
myogenesis-regulating glycosidase, transcript variant X1
myogenesis-regulating glycosidase, transcript variant X2
myogenesis-regulating glycosidase isoform X1
myogenesis-regulating glycosidase isoform X2
centrosomal protein of 120 kDa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centrosomal protein of 120 kDa, transcript variant X2
centrosomal protein of 120 kDa isoform X2
centrosomal protein of 120 kDa isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X6
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
tyrosine-protein phosphatase 99A, transcript variant X2
tyrosine-protein phosphatase 99A, transcript variant X3
tyrosine-protein phosphatase 99A, transcript variant X5
tyrosine-protein phosphatase 99A, transcript variant X1
tyrosine-protein phosphatase 99A, transcript variant X4
tyrosine-protein phosphatase 99A, transcript variant X6
tyrosine-protein phosphatase 99A, transcript variant X13
tyrosine-protein phosphatase 99A, transcript variant X7
tyrosine-protein phosphatase 99A, transcript variant X9
tyrosine-protein phosphatase 99A, transcript variant X11
tyrosine-protein phosphatase 99A, transcript variant X14
tyrosine-protein phosphatase 99A, transcript variant X8
tyrosine-protein phosphatase 99A, transcript variant X12
tyrosine-protein phosphatase 99A, transcript variant X15
tyrosine-protein phosphatase 99A, transcript variant X10
tyrosine-protein phosphatase 99A isoform X3
tyrosine-protein phosphatase 99A isoform X2
tyrosine-protein phosphatase 99A isoform X1
tyrosine-protein phosphatase 99A isoform X4
tyrosine-protein phosphatase 99A isoform X5
uncharacterized LOC124425782, transcript variant X1
uncharacterized LOC124425782, transcript variant X2
irregular chiasm C-roughest protein-like, transcript variant X3
irregular chiasm C-roughest protein-like, transcript variant X2
irregular chiasm C-roughest protein-like, transcript variant X1
irregular chiasm C-roughest protein-like, transcript variant X4
irregular chiasm C-roughest protein-like, transcript variant X5
irregular chiasm C-roughest protein-like isoform X3
irregular chiasm C-roughest protein-like isoform X2
irregular chiasm C-roughest protein-like isoform X1
irregular chiasm C-roughest protein-like isoform X4
irregular chiasm C-roughest protein-like isoform X5
retinoblastoma-binding protein 5 homolog, transcript variant X3
retinoblastoma-binding protein 5 homolog, transcript variant X2
retinoblastoma-binding protein 5 homolog, transcript variant X1
retinoblastoma-binding protein 5 homolog
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X5
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X6
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X5
dynein axonemal light chain 1-like, transcript variant X1
dynein axonemal light chain 1-like, transcript variant X7
dynein axonemal light chain 1-like isoform X1
dynein axonemal light chain 1-like isoform X4
dynein axonemal light chain 1-like, transcript variant X3
dynein axonemal light chain 1-like, transcript variant X9
dynein axonemal light chain 1-like, transcript variant X11
dynein axonemal light chain 1-like, transcript variant X10
dynein axonemal light chain 1-like, transcript variant X8
dynein axonemal light chain 1-like, transcript variant X4
dynein axonemal light chain 1-like, transcript variant X2
dynein axonemal light chain 1-like, transcript variant X5
dynein axonemal light chain 1-like isoform X2
dynein axonemal light chain 1-like, transcript variant X6
dynein axonemal light chain 1-like isoform X3
dynein axonemal light chain 1-like isoform X5
DNA polymerase epsilon subunit 2, transcript variant X1
DNA polymerase epsilon subunit 2, transcript variant X2
DNA polymerase epsilon subunit 2 isoform X1
DNA polymerase epsilon subunit 2 isoform X2
tetratricopeptide repeat protein 30A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X1
tetratricopeptide repeat protein 30A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tetratricopeptide repeat protein 30A isoform X1
tetratricopeptide repeat protein 30A isoform X2
tetratricopeptide repeat protein 30A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tetratricopeptide repeat protein 30A isoform X3
tetratricopeptide repeat protein 30A isoform X4
26S proteasome non-ATPase regulatory subunit 9, transcript variant X1
26S proteasome non-ATPase regulatory subunit 9, transcript variant X2
26S proteasome non-ATPase regulatory subunit 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 135 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
hemicentin-2-like, transcript variant X3
hemicentin-2-like, transcript variant X2
hemicentin-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
elongation of very long chain fatty acids protein 1-like, transcript variant X1
elongation of very long chain fatty acids protein 1-like isoform X1
elongation of very long chain fatty acids protein 1-like, transcript variant X2
elongation of very long chain fatty acids protein 1-like isoform X2
cysteine sulfinic acid decarboxylase-like
protein UXT homolog, transcript variant X2
protein UXT homolog, transcript variant X1
doublesex- and mab-3-related transcription factor dmd-3-like, transcript variant X5
doublesex- and mab-3-related transcription factor dmd-3-like, transcript variant X4
doublesex- and mab-3-related transcription factor dmd-3-like, transcript variant X2
doublesex- and mab-3-related transcription factor dmd-3-like, transcript variant X1
doublesex- and mab-3-related transcription factor dmd-3-like, transcript variant X3
uncharacterized protein LOC124425721 isoform X1
doublesex- and mab-3-related transcription factor dmd-3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC124425721 isoform X2
doublesex- and mab-3-related transcription factor dmd-3-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
doublesex- and mab-3-related transcription factor dmd-3-like isoform X3
homeobox protein prospero-like, transcript variant X3
homeobox protein prospero-like, transcript variant X2
homeobox protein prospero-like, transcript variant X1
homeobox protein prospero-like isoform X3
homeobox protein prospero-like isoform X2
homeobox protein prospero-like isoform X1
uncharacterized protein DDB_G0286105-like, transcript variant X4
uncharacterized protein DDB_G0286105-like, transcript variant X3
uncharacterized protein DDB_G0286105-like, transcript variant X1
uncharacterized protein DDB_G0286105-like, transcript variant X5
uncharacterized protein DDB_G0286105-like, transcript variant X2
uncharacterized protein DDB_G0286105-like, transcript variant X6
uncharacterized protein DDB_G0286105-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124425365, transcript variant X1
uncharacterized LOC124425365, transcript variant X3
uncharacterized LOC124425365, transcript variant X4
uncharacterized LOC124425365, transcript variant X2
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X1
C-1-tetrahydrofolate synthase, cytoplasmic isoform X1
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X2
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X3
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X4
C-1-tetrahydrofolate synthase, cytoplasmic isoform X2
C-1-tetrahydrofolate synthase, cytoplasmic isoform X3
ubiquinol-cytochrome-c reductase complex assembly factor 2
probable methyltransferase-like protein 15 homolog
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
choline-phosphate cytidylyltransferase A-like, transcript variant X3
choline-phosphate cytidylyltransferase A-like, transcript variant X1
choline-phosphate cytidylyltransferase A-like, transcript variant X2
choline-phosphate cytidylyltransferase A-like, transcript variant X5
choline-phosphate cytidylyltransferase A-like, transcript variant X4
choline-phosphate cytidylyltransferase A-like, transcript variant X6
choline-phosphate cytidylyltransferase A-like isoform X1
choline-phosphate cytidylyltransferase A-like isoform X2
uncharacterized LOC124425727, transcript variant X1
uncharacterized LOC124425727, transcript variant X3
uncharacterized LOC124425727, transcript variant X2
uncharacterized protein LOC124425727 isoform X1
uncharacterized protein LOC124425727 isoform X2
uncharacterized protein LOC124425727 isoform X3
uncharacterized LOC124425727, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC124425727 isoform X4
myosin regulatory light chain sqh-like, transcript variant X1
myosin regulatory light chain sqh-like, transcript variant X3
myosin regulatory light chain sqh-like, transcript variant X2
myosin regulatory light chain sqh-like isoform X1
repetitive organellar protein-like isoform X3
myosin regulatory light chain 2, smooth muscle major isoform-like isoform X2
signal recognition particle 54 kDa protein
protein spindle-F, transcript variant X1
protein spindle-F, transcript variant X4
protein spindle-F, transcript variant X2
protein spindle-F, transcript variant X3
39S ribosomal protein L32, mitochondrial
N6-adenosine-methyltransferase subunit METTL3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
N6-adenosine-methyltransferase subunit METTL3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
N6-adenosine-methyltransferase subunit METTL3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
N6-adenosine-methyltransferase subunit METTL3 isoform X1
N6-adenosine-methyltransferase subunit METTL3 isoform X2
rho guanine nucleotide exchange factor 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
rho guanine nucleotide exchange factor 3-like, transcript variant X2
rho guanine nucleotide exchange factor 3-like isoform X1
rho guanine nucleotide exchange factor 3-like isoform X2
probable methylthioribulose-1-phosphate dehydratase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable methylthioribulose-1-phosphate dehydratase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable methylthioribulose-1-phosphate dehydratase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
probable methylthioribulose-1-phosphate dehydratase
COMM domain-containing protein 10, transcript variant X1
COMM domain-containing protein 10, transcript variant X3
COMM domain-containing protein 10, transcript variant X2
COMM domain-containing protein 10 isoform X1
COMM domain-containing protein 10 isoform X3
COMM domain-containing protein 10 isoform X2
uncharacterized LOC124425508, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124425508, transcript variant X2
uncharacterized LOC124425508, transcript variant X5
uncharacterized LOC124425508, transcript variant X1
uncharacterized LOC124425508, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC124425508 isoform X1
uncharacterized protein LOC124425508 isoform X2
ankyrin repeat domain-containing protein 16-like
latrophilin Cirl-like, transcript variant X11
latrophilin Cirl-like, transcript variant X7
latrophilin Cirl-like, transcript variant X3
latrophilin Cirl-like, transcript variant X9
latrophilin Cirl-like, transcript variant X4
latrophilin Cirl-like, transcript variant X5
latrophilin Cirl-like, transcript variant X14
latrophilin Cirl-like, transcript variant X15
latrophilin Cirl-like, transcript variant X1
latrophilin Cirl-like, transcript variant X13
latrophilin Cirl-like, transcript variant X10
latrophilin Cirl-like, transcript variant X8
latrophilin Cirl-like, transcript variant X2
latrophilin Cirl-like, transcript variant X12
latrophilin Cirl-like, transcript variant X6
latrophilin Cirl-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial import inner membrane translocase subunit TIM50-C-like, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM50-C-like isoform X1
mitochondrial import inner membrane translocase subunit TIM50-C-like, transcript variant X2
mitochondrial import inner membrane translocase subunit TIM50-C-like isoform X2
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X4
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X2
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X3
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X1
uncharacterized protein LOC124425716 isoform X1
uncharacterized LOC124425770, transcript variant X6
uncharacterized LOC124425770, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124425770, transcript variant X8
uncharacterized LOC124425770, transcript variant X1
uncharacterized LOC124425770, transcript variant X2
uncharacterized LOC124425770, transcript variant X3
uncharacterized LOC124425770, transcript variant X4
uncharacterized LOC124425770, transcript variant X5
uncharacterized protein LOC124425770 isoform X1
uncharacterized protein LOC124425770 isoform X2
uncharacterized protein LOC124425770 isoform X3
uncharacterized protein LOC124425770 isoform X5
uncharacterized protein LOC124425770 isoform X4
glycine receptor subunit alpha-2, transcript variant X1
glycine receptor subunit alpha-2, transcript variant X2
glycine receptor subunit alpha-2, transcript variant X3
glycine receptor subunit alpha-2, transcript variant X4
glycine receptor subunit alpha-4 isoform X1
glycine receptor subunit alpha-4 isoform X2
glycine receptor subunit alpha-2 isoform X3
potassium voltage-gated channel protein Shal, transcript variant X4
potassium voltage-gated channel protein Shal, transcript variant X2
potassium voltage-gated channel protein Shal, transcript variant X1
potassium voltage-gated channel protein Shal, transcript variant X3
potassium voltage-gated channel protein Shal isoform X3
potassium voltage-gated channel protein Shal isoform X1
potassium voltage-gated channel protein Shal isoform X2
potassium voltage-gated channel protein Shal, transcript variant X6
potassium voltage-gated channel protein Shal, transcript variant X5
potassium voltage-gated channel protein Shal isoform X5
potassium voltage-gated channel protein Shal isoform X4
adenosylhomocysteinase-like 1, transcript variant X1
adenosylhomocysteinase-like 1, transcript variant X3
adenosylhomocysteinase-like 1, transcript variant X4
rho GTPase-activating protein 190, transcript variant X3
rho GTPase-activating protein 190, transcript variant X4
rho GTPase-activating protein 190, transcript variant X1
rho GTPase-activating protein 190, transcript variant X2
rho GTPase-activating protein 190 isoform X2
rho GTPase-activating protein 190 isoform X3
rho GTPase-activating protein 190 isoform X1
adenosylhomocysteinase-like 1, transcript variant X2
adenosylhomocysteinase-like 1, transcript variant X6
adenosylhomocysteinase-like 1, transcript variant X8
adenosylhomocysteinase-like 1 isoform X1
adenosylhomocysteinase-like 1 isoform X2
adenosylhomocysteinase-like 1 isoform X3
adenosylhomocysteinase-like 1 isoform X6
adenosylhomocysteinase-like 1, transcript variant X5
adenosylhomocysteinase-like 1 isoform X4
adenosylhomocysteinase-like 1, transcript variant X7
adenosylhomocysteinase-like 1 isoform X5
uncharacterized LOC124425764, transcript variant X1
uncharacterized LOC124425764, transcript variant X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X4
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2-like isoform X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X1
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X2
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X1
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X3
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X2
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X1
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X2
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X3
RNA polymerase I-specific transcription initiation factor RRN3, transcript variant X2
RNA polymerase I-specific transcription initiation factor RRN3, transcript variant X1
RNA polymerase I-specific transcription initiation factor RRN3 isoform X2
RNA polymerase I-specific transcription initiation factor RRN3 isoform X1
diacylglycerol lipase-beta-like, transcript variant X4
diacylglycerol lipase-beta-like, transcript variant X3
diacylglycerol lipase-beta-like, transcript variant X5
diacylglycerol lipase-beta-like, transcript variant X2
diacylglycerol lipase-beta-like, transcript variant X1
diacylglycerol lipase-beta-like, transcript variant X6
diacylglycerol lipase-beta-like isoform X2
diacylglycerol lipase-beta-like isoform X1
diacylglycerol lipase-beta-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X2
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X3
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X1
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X5
uncharacterized protein LOC124425345 isoform X2
V-set and immunoglobulin domain-containing protein 2-like isoform X3
V-set and immunoglobulin domain-containing protein 2-like isoform X1
uncharacterized protein LOC124425345 isoform X5
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X4
V-set and immunoglobulin domain-containing protein 2-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124425470, transcript variant X3
uncharacterized LOC124425470, transcript variant X2
uncharacterized LOC124425470, transcript variant X1
uncharacterized protein LOC124425470 isoform X2
uncharacterized protein LOC124425470 isoform X1
uncharacterized LOC124425606, transcript variant X1
uncharacterized LOC124425606, transcript variant X5
uncharacterized LOC124425606, transcript variant X4
uncharacterized LOC124425606, transcript variant X3
uncharacterized LOC124425606, transcript variant X2
coiled-coil domain-containing protein 142, transcript variant X1
coiled-coil domain-containing protein 142 isoform X1
coiled-coil domain-containing protein 142, transcript variant X3
coiled-coil domain-containing protein 142, transcript variant X4
coiled-coil domain-containing protein 142, transcript variant X2
uncharacterized protein LOC124425605 isoform X2
uncharacterized protein LOC124425605 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Fanconi anemia group M protein, transcript variant X2
Fanconi anemia group M protein, transcript variant X1
Fanconi anemia group M protein, transcript variant X3
Fanconi anemia group M protein isoform X2
Fanconi anemia group M protein isoform X1
Fanconi anemia group M protein isoform X3
5'-3' exonuclease PLD3-like, transcript variant X1
5'-3' exonuclease PLD3-like, transcript variant X2
5'-3' exonuclease PLD3-like, transcript variant X5
5'-3' exonuclease PLD3-like, transcript variant X3
5'-3' exonuclease PLD3-like, transcript variant X4
5'-3' exonuclease PLD3-like, transcript variant X6
uncharacterized LOC124425603, transcript variant X6
uncharacterized LOC124425603, transcript variant X5
uncharacterized LOC124425603, transcript variant X3
uncharacterized LOC124425603, transcript variant X2
uncharacterized LOC124425603, transcript variant X4
uncharacterized LOC124425603, transcript variant X1
uncharacterized protein LOC124425603 isoform X1
uncharacterized protein LOC124425603 isoform X2
AF4/FMR2 family member lilli-like, transcript variant X6
AF4/FMR2 family member lilli-like, transcript variant X9
AF4/FMR2 family member lilli-like, transcript variant X3
AF4/FMR2 family member lilli-like, transcript variant X11
AF4/FMR2 family member lilli-like, transcript variant X4
AF4/FMR2 family member lilli-like, transcript variant X1
AF4/FMR2 family member lilli-like, transcript variant X2
AF4/FMR2 family member lilli-like, transcript variant X8
AF4/FMR2 family member lilli-like, transcript variant X10
AF4/FMR2 family member lilli-like, transcript variant X5
AF4/FMR2 family member lilli-like, transcript variant X7
uncharacterized protein LOC124425601 isoform X1
AF4/FMR2 family member lilli-like isoform X2
dynein axonemal assembly factor 11-like, transcript variant X5
dynein axonemal assembly factor 11-like, transcript variant X4
dynein axonemal assembly factor 11-like, transcript variant X3
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial-like isoform X3
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial-like isoform X4
dynein axonemal assembly factor 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dynein axonemal assembly factor 11-like isoform X1
dynein axonemal assembly factor 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dynein axonemal assembly factor 11-like isoform X2
protein diaphanous, transcript variant X8
protein diaphanous, transcript variant X7
protein diaphanous, transcript variant X4
protein diaphanous, transcript variant X3
protein diaphanous, transcript variant X1
protein diaphanous, transcript variant X6
protein diaphanous, transcript variant X5
protein diaphanous, transcript variant X2
general transcription factor IIH subunit 4, transcript variant X2
general transcription factor IIH subunit 4, transcript variant X3
general transcription factor IIH subunit 4, transcript variant X1
general transcription factor IIH subunit 4 isoform X1
general transcription factor IIH subunit 4 isoform X2
general transcription factor IIH subunit 4 isoform X3
adrenodoxin-like protein 1, mitochondrial
sprouty-related, EVH1 domain-containing protein 1, transcript variant X4
sprouty-related, EVH1 domain-containing protein 1, transcript variant X5
sprouty-related, EVH1 domain-containing protein 1, transcript variant X2
sprouty-related, EVH1 domain-containing protein 1, transcript variant X3
sprouty-related, EVH1 domain-containing protein 1, transcript variant X1
sprouty-related, EVH1 domain-containing protein 2 isoform X4
sprouty-related, EVH1 domain-containing protein 1 isoform X3
sprouty-related, EVH1 domain-containing protein 3 isoform X2
sprouty-related, EVH1 domain-containing protein 1 isoform X1
multiple C2 and transmembrane domain-containing protein, transcript variant X4
multiple C2 and transmembrane domain-containing protein, transcript variant X1
multiple C2 and transmembrane domain-containing protein, transcript variant X2
multiple C2 and transmembrane domain-containing protein, transcript variant X7
multiple C2 and transmembrane domain-containing protein, transcript variant X3
multiple C2 and transmembrane domain-containing protein, transcript variant X5
multiple C2 and transmembrane domain-containing protein isoform X3
multiple C2 and transmembrane domain-containing protein isoform X1
multiple C2 and transmembrane domain-containing protein isoform X2
multiple C2 and transmembrane domain-containing protein isoform X4
multiple C2 and transmembrane domain-containing protein, transcript variant X8
multiple C2 and transmembrane domain-containing protein isoform X6
multiple C2 and transmembrane domain-containing protein, transcript variant X6
multiple C2 and transmembrane domain-containing protein isoform X5
NADH-quinone oxidoreductase subunit B-like
MAU2 chromatid cohesion factor homolog, transcript variant X2
MAU2 chromatid cohesion factor homolog, transcript variant X1
transcriptional repressor p66-beta-like, transcript variant X3
transcriptional repressor p66-beta-like, transcript variant X5
transcriptional repressor p66-beta-like, transcript variant X8
transcriptional repressor p66-beta-like, transcript variant X7
transcriptional repressor p66-beta-like, transcript variant X12
transcriptional repressor p66-beta-like isoform X5
transcriptional repressor p66-beta-like isoform X7
transcriptional repressor p66-beta-like, transcript variant X4
transcriptional repressor p66-beta-like isoform X3
transcriptional repressor p66-beta-like isoform X4
transcriptional repressor p66-beta-like, transcript variant X10
transcriptional repressor p66-beta-like, transcript variant X14
transcriptional repressor p66-beta-like, transcript variant X9
transcriptional repressor p66-beta-like, transcript variant X13
transcriptional repressor p66-beta-like, transcript variant X16
transcriptional repressor p66-beta-like, transcript variant X1
transcriptional repressor p66-beta-like, transcript variant X6
transcriptional repressor p66-beta-like, transcript variant X2
transcriptional repressor p66-beta-like isoform X1
transcriptional repressor p66-beta-like isoform X10
transcriptional repressor p66-beta-like isoform X6
transcriptional repressor p66-beta-like isoform X2
transcriptional repressor p66-beta-like, transcript variant X11
transcriptional repressor p66-beta-like, transcript variant X15
transcriptional repressor p66-beta-like isoform X8
transcriptional repressor p66-beta-like isoform X9
uncharacterized LOC124425658, transcript variant X1
uncharacterized LOC124425658, transcript variant X2
uncharacterized LOC124425772, transcript variant X2
uncharacterized LOC124425772, transcript variant X1
uncharacterized LOC124425772, transcript variant X3
uncharacterized LOC124425772, transcript variant X4
uncharacterized protein LOC124425772 isoform X1
uncharacterized protein LOC124425772 isoform X2
uncharacterized LOC124425772, transcript variant X5
protein prickle-like, transcript variant X3
protein prickle-like, transcript variant X4
protein prickle-like, transcript variant X5
protein prickle-like, transcript variant X2
protein prickle-like, transcript variant X1
prickle planar cell polarity protein 3-like isoform X3
sulfotransferase 1C4-like, transcript variant X1
sulfotransferase 1C4-like, transcript variant X2
PX domain-containing protein kinase-like protein, transcript variant X1
PX domain-containing protein kinase-like protein isoform X1
PX domain-containing protein kinase-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
PX domain-containing protein kinase-like protein isoform X2
eukaryotic translation initiation factor 2D
ELAV-like protein 1, transcript variant X4
ELAV-like protein 1, transcript variant X3
ELAV-like protein 1, transcript variant X2
ELAV-like protein 1, transcript variant X5
ELAV-like protein 1, transcript variant X6
ELAV-like protein 1, transcript variant X7
ELAV-like protein 1, transcript variant X11
ELAV-like protein 1, transcript variant X1
ELAV-like protein 1, transcript variant X16
ELAV-like protein 1, transcript variant X9
ELAV-like protein 1, transcript variant X17
ELAV-like protein 1, transcript variant X14
ELAV-like protein 1, transcript variant X13
ELAV-like protein 1, transcript variant X8
ELAV-like protein 1, transcript variant X15
ELAV-like protein 1, transcript variant X12
ELAV-like protein 1, transcript variant X10
ELAV-like protein 1, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cytosolic carboxypeptidase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cytosolic carboxypeptidase 6, transcript variant X2
RNA-binding protein 5-like, transcript variant X1
RNA-binding protein 5-like, transcript variant X2
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like isoform X2
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like isoform X1
5-aminolevulinate synthase, erythroid-specific, mitochondrial, transcript variant X1
5-aminolevulinate synthase, erythroid-specific, mitochondrial, transcript variant X2
5-aminolevulinate synthase, erythroid-specific, mitochondrial isoform X2
5-aminolevulinate synthase, erythroid-specific, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 237 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124425595, transcript variant X2
uncharacterized LOC124425595, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X4
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X2
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X3
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X1
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X5
gamma-aminobutyric acid type B receptor subunit 2 isoform X1
gamma-aminobutyric acid type B receptor subunit 2 isoform X2
uncharacterized LOC124425574, transcript variant X4
uncharacterized LOC124425574, transcript variant X1
uncharacterized LOC124425574, transcript variant X6
uncharacterized LOC124425574, transcript variant X5
uncharacterized LOC124425574, transcript variant X2
uncharacterized LOC124425574, transcript variant X3
protein Wnt-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein Wnt-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-glucuronosyltransferase 2B14-like, transcript variant X3
UDP-glucuronosyltransferase 2B14-like, transcript variant X1
UDP-glucuronosyltransferase 2B14-like, transcript variant X2
RING finger and CHY zinc finger domain-containing protein 1
mediator of RNA polymerase II transcription subunit 27-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 27-like, transcript variant X3
mediator of RNA polymerase II transcription subunit 27-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 27-like isoform X2
mediator of RNA polymerase II transcription subunit 27-like isoform X1
uncharacterized protein LOC124425540 isoform X1
uncharacterized LOC124425541, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124425541, transcript variant X1
uncharacterized LOC124425541, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124425541, transcript variant X4
mitochondrial dimethyladenosine transferase 1
cytochrome c oxidase assembly factor 3, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 1, transcript variant X8
regulating synaptic membrane exocytosis protein 1, transcript variant X5
regulating synaptic membrane exocytosis protein 1, transcript variant X6
regulating synaptic membrane exocytosis protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 1, transcript variant X3
regulating synaptic membrane exocytosis protein 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 1, transcript variant X13
regulating synaptic membrane exocytosis protein 1, transcript variant X10
regulating synaptic membrane exocytosis protein 1, transcript variant X11
regulating synaptic membrane exocytosis protein 1, transcript variant X4
regulating synaptic membrane exocytosis protein 1 isoform X1
regulating synaptic membrane exocytosis protein 1 isoform X4
regulating synaptic membrane exocytosis protein 1 isoform X5
regulating synaptic membrane exocytosis protein 1 isoform X2
regulating synaptic membrane exocytosis protein 1 isoform X3
regulating synaptic membrane exocytosis protein 1 isoform X9
regulating synaptic membrane exocytosis protein 1 isoform X10
regulating synaptic membrane exocytosis protein 1 isoform X7
regulating synaptic membrane exocytosis protein 1 isoform X8
regulating synaptic membrane exocytosis protein 1, transcript variant X9
regulating synaptic membrane exocytosis protein 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124425492, transcript variant X3
uncharacterized LOC124425492, transcript variant X4
uncharacterized LOC124425492, transcript variant X1
uncharacterized LOC124425492, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
growth factor receptor-bound protein 2, transcript variant X5
growth factor receptor-bound protein 2, transcript variant X3
growth factor receptor-bound protein 2, transcript variant X1
growth factor receptor-bound protein 2, transcript variant X4
growth factor receptor-bound protein 2, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC1
protein arginine N-methyltransferase 6, transcript variant X4
protein arginine N-methyltransferase 6, transcript variant X2
protein arginine N-methyltransferase 6, transcript variant X1
protein arginine N-methyltransferase 6, transcript variant X3
protein arginine N-methyltransferase 6 isoform X1
protein arginine N-methyltransferase 6 isoform X2
probable protein arginine N-methyltransferase 6.1 isoform X3
uncharacterized LOC124425484, transcript variant X1
uncharacterized LOC124425484, transcript variant X2
uncharacterized LOC124425484, transcript variant X3
uncharacterized protein LOC124425484 isoform X2
uncharacterized protein LOC124425484 isoform X1
uncharacterized LOC124425486, transcript variant X7
uncharacterized LOC124425486, transcript variant X2
uncharacterized LOC124425486, transcript variant X3
uncharacterized LOC124425486, transcript variant X6
uncharacterized LOC124425486, transcript variant X1
uncharacterized LOC124425486, transcript variant X4
uncharacterized LOC124425486, transcript variant X5
intraflagellar transport protein 46 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like isoform X1
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
abscission/NoCut checkpoint regulator, transcript variant X1
abscission/NoCut checkpoint regulator, transcript variant X2
abscission/NoCut checkpoint regulator, transcript variant X3
abscission/NoCut checkpoint regulator, transcript variant X5
abscission/NoCut checkpoint regulator, transcript variant X4
abscission/NoCut checkpoint regulator, transcript variant X6
abscission/NoCut checkpoint regulator isoform X1
abscission/NoCut checkpoint regulator isoform X2
BAG domain-containing protein Samui-like, transcript variant X1
BAG domain-containing protein Samui-like, transcript variant X2
BAG domain-containing protein Samui-like isoform X1
BAG domain-containing protein Samui-like isoform X2
dual specificity mitogen-activated protein kinase kinase dSOR1, transcript variant X1
dual specificity mitogen-activated protein kinase kinase dSOR1, transcript variant X3
dual specificity mitogen-activated protein kinase kinase dSOR1, transcript variant X2
dual specificity mitogen-activated protein kinase kinase dSOR1 isoform X1
dual specificity mitogen-activated protein kinase kinase dSOR1 isoform X2
sodium/potassium-transporting ATPase subunit alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
synaptic vesicle glycoprotein 2B, transcript variant X1
synaptic vesicle glycoprotein 2B, transcript variant X2
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
E3 ubiquitin-protein ligase arih1, transcript variant X5
E3 ubiquitin-protein ligase arih1, transcript variant X2
E3 ubiquitin-protein ligase arih1, transcript variant X1
E3 ubiquitin-protein ligase arih1, transcript variant X8
E3 ubiquitin-protein ligase arih1, transcript variant X6
E3 ubiquitin-protein ligase arih1, transcript variant X7
E3 ubiquitin-protein ligase arih1, transcript variant X3
E3 ubiquitin-protein ligase arih1, transcript variant X4
serine/threonine-protein kinase ULK3, transcript variant X2
serine/threonine-protein kinase ULK3, transcript variant X1
serine/threonine-protein kinase ULK3, transcript variant X5
serine/threonine-protein kinase ULK3, transcript variant X3
serine/threonine-protein kinase ULK3, transcript variant X4
serine/threonine-protein kinase ULK3 isoform X1
serine/threonine-protein kinase ULK3 isoform X2
serine/threonine-protein kinase ULK3 isoform X4
serine/threonine-protein kinase ULK3 isoform X3
uncharacterized LOC124425551, transcript variant X1
uncharacterized LOC124425551, transcript variant X4
uncharacterized LOC124425551, transcript variant X5
uncharacterized protein LOC124425551 isoform X4
uncharacterized LOC124425551, transcript variant X3
uncharacterized LOC124425551, transcript variant X6
uncharacterized protein LOC124425551 isoform X5
uncharacterized LOC124425551, transcript variant X2
uncharacterized protein LOC124425551 isoform X2
uncharacterized protein LOC124425551 isoform X1
uncharacterized protein LOC124425551 isoform X3
uncharacterized protein LOC124425553 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 66% coverage of the annotated genomic feature by RNAseq alignments
zwei Ig domain protein zig-8-like, transcript variant X3
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like, transcript variant X1
zwei Ig domain protein zig-8-like, transcript variant X6
zwei Ig domain protein zig-8-like, transcript variant X4
zwei Ig domain protein zig-8-like, transcript variant X5
zwei Ig domain protein zig-8-like isoform X1
zwei Ig domain protein zig-8-like isoform X2
gonadotropin-releasing hormone receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
gonadotropin-releasing hormone receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gonadotropin-releasing hormone receptor isoform X1
gonadotropin-releasing hormone receptor isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Wilms tumor protein homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Wilms tumor protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Wilms tumor protein homolog, transcript variant X4
Wilms tumor protein homolog, transcript variant X3
Wilms tumor protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cilia- and flagella-associated protein 43-like
zinc finger protein basonuclin-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger protein basonuclin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein basonuclin-2-like, transcript variant X4
zinc finger protein basonuclin-2-like, transcript variant X1
zinc finger protein basonuclin-2-like isoform X2
zinc finger protein basonuclin-2-like isoform X1
zinc finger protein basonuclin-2-like isoform X3
zinc finger protein basonuclin-2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC124425466 isoform X4
nitrogen assimilation transcription factor nit-4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
putative leucine-rich repeat-containing protein DDB_G0290503
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 64% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124425526, transcript variant X2
uncharacterized LOC124425526, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124425526 isoform X2
uncharacterized protein LOC124425526 isoform X1
G-patch domain and KOW motifs-containing protein
uncharacterized LOC124425522, transcript variant X2
uncharacterized LOC124425522, transcript variant X1
WD repeat-containing protein 37-like, transcript variant X5
WD repeat-containing protein 37-like, transcript variant X4
WD repeat-containing protein 37-like, transcript variant X3
WD repeat-containing protein 37-like, transcript variant X1
WD repeat-containing protein 37-like, transcript variant X2
katanin p60 ATPase-containing subunit A-like 2 isoform X1
WD repeat-containing protein 37-like, transcript variant X8
survival motor neuron protein, transcript variant X3
survival motor neuron protein, transcript variant X2
survival motor neuron protein, transcript variant X1
survival motor neuron protein isoform X3
survival of motor neuron protein isoform X1
survival of motor neuron protein isoform X2
WD repeat-containing protein 37-like, transcript variant X6
WD repeat-containing protein 37-like, transcript variant X7
WD repeat-containing protein 37-like isoform X2
WD repeat-containing protein 37-like, transcript variant X9
WD repeat-containing protein 37-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
aldo-keto reductase family 1 member A1-like
adenylosuccinate synthetase, transcript variant X1
adenylosuccinate synthetase, transcript variant X2
homeobox protein engrailed-2-B, transcript variant X1
homeobox protein engrailed-2-B, transcript variant X2
homeobox protein engrailed-2-B isoform X1
homeobox protein engrailed-2-B isoform X2
cilia- and flagella-associated protein 157
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DNA polymerase epsilon catalytic subunit 1, transcript variant X2
DNA polymerase epsilon catalytic subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA polymerase epsilon catalytic subunit 1, transcript variant X1
DNA polymerase epsilon catalytic subunit 1 isoform X2
DNA polymerase epsilon catalytic subunit 1 isoform X1
DNA polymerase epsilon catalytic subunit 1, transcript variant X4
DNA polymerase epsilon catalytic subunit 1 isoform X3
ATP synthase-coupling factor 6, mitochondrial, transcript variant X1
ATP synthase-coupling factor 6, mitochondrial, transcript variant X2
ATP synthase-coupling factor 6, mitochondrial, transcript variant X4
ATP synthase-coupling factor 6, mitochondrial, transcript variant X3
ATP synthase-coupling factor 6, mitochondrial isoform X1
ATP synthase-coupling factor 6, mitochondrial isoform X2
ATP synthase-coupling factor 6, mitochondrial isoform X3
paired box pox-meso protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
paired box pox-meso protein-like, transcript variant X1
paired box pox-meso protein-like, transcript variant X4
paired box pox-meso protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
paired box pox-meso protein-like isoform X2
paired box pox-meso protein-like isoform X1
paired box pox-meso protein-like, transcript variant X5
snRNA-activating protein complex subunit 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
snRNA-activating protein complex subunit 3 isoform X1
snRNA-activating protein complex subunit 3, transcript variant X2
snRNA-activating protein complex subunit 3 isoform X2
protein O-mannosyl-transferase TMTC4-like, transcript variant X2
protein O-mannosyl-transferase TMTC4-like, transcript variant X1
protein O-mannosyl-transferase TMTC4-like isoform X1
protein O-mannosyl-transferase TMTC4-like isoform X2
ribosome biogenesis protein NOP53, transcript variant X1
ribosome biogenesis protein NOP53, transcript variant X2
ribosome biogenesis protein NOP53, transcript variant X3
uncharacterized LOC124425707, transcript variant X1
uncharacterized LOC124425707, transcript variant X2
very low-density lipoprotein receptor-like, transcript variant X2
very low-density lipoprotein receptor-like, transcript variant X1
very low-density lipoprotein receptor-like, transcript variant X3
very low-density lipoprotein receptor-like, transcript variant X5
very low-density lipoprotein receptor-like, transcript variant X4
very low-density lipoprotein receptor-like, transcript variant X7
very low-density lipoprotein receptor-like, transcript variant X6
very low-density lipoprotein receptor-like isoform X1
very low-density lipoprotein receptor-like isoform X2
very low-density lipoprotein receptor-like isoform X4
very low-density lipoprotein receptor-like isoform X3
very low-density lipoprotein receptor-like isoform X6
low-density lipoprotein receptor-like isoform X5
GATOR complex protein NPRL3, transcript variant X1
GATOR complex protein NPRL3, transcript variant X2
uncharacterized LOC124425706, transcript variant X2
uncharacterized LOC124425706, transcript variant X3
uncharacterized LOC124425706, transcript variant X1
uncharacterized protein LOC124425706 isoform X2
uncharacterized protein LOC124425706 isoform X1
pleckstrin homology domain-containing family J member 1-like
pleiotropic regulator 1, transcript variant X2
pleiotropic regulator 1, transcript variant X1
uncharacterized LOC124425812, transcript variant X1
uncharacterized protein LOC124425812 isoform X1
uncharacterized LOC124425812, transcript variant X2
uncharacterized protein LOC124425812 isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
neuralized-like protein 2, transcript variant X2
neuralized-like protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
probable serine/threonine-protein kinase drkD
nucleoplasmin-like protein, transcript variant X2
nucleoplasmin-like protein, transcript variant X1
nucleoplasmin-like protein, transcript variant X3
myosin heavy chain, skeletal muscle, adult-like
homeobox protein HMX1-like, transcript variant X4
homeobox protein HMX1-like, transcript variant X2
homeobox protein HMX1-like, transcript variant X3
homeobox protein HMX1-like, transcript variant X1
muscle segmentation homeobox-like, transcript variant X1
muscle segmentation homeobox-like, transcript variant X2
myb-like protein Q, transcript variant X2
myb-like protein Q, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
outer dense fiber protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
outer dense fiber protein 3-like, transcript variant X2
outer dense fiber protein 3-like isoform X1
uncharacterized protein LOC124425440 isoform X2
28S ribosomal protein S29, mitochondrial
glutamate receptor ionotropic, kainate glr-3-like, transcript variant X1
glutamate receptor ionotropic, kainate glr-3-like, transcript variant X2
glutamate receptor ionotropic, kainate glr-3-like isoform X1
glutamate receptor ionotropic, kainate glr-3-like isoform X2
uncharacterized LOC124425599, transcript variant X2
uncharacterized LOC124425599, transcript variant X1
protein spaetzle 3, transcript variant X3
protein spaetzle 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein spaetzle 3, transcript variant X1
protein spaetzle 3, transcript variant X2
uncharacterized LOC124425565, transcript variant X1
uncharacterized LOC124425565, transcript variant X2
uncharacterized protein LOC124425565 isoform X2
uncharacterized protein LOC124425565 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124425379, transcript variant X2
uncharacterized LOC124425379, transcript variant X1
chromosome-associated kinesin KIF4, transcript variant X2
chromosome-associated kinesin KIF4, transcript variant X1
zinc transporter 9, transcript variant X5
zinc transporter 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc transporter 9, transcript variant X2
zinc transporter 9, transcript variant X3
zinc transporter 9, transcript variant X1
CD151 antigen-like, transcript variant X1
CD151 antigen-like, transcript variant X2
CD151 antigen-like, transcript variant X3
putative uncharacterized protein DDB_G0271974
tropomyosin-1, isoforms 33/34 isoform X10
tropomyosin-1, isoforms 33/34 isoform X5
tropomyosin-1, isoforms 33/34 isoform X6
tropomyosin-1, isoforms 33/34 isoform X1
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 78% coverage of the annotated genomic feature by RNAseq alignments
myb-like protein O, transcript variant X2
myb-like protein O, transcript variant X1
heterogeneous nuclear ribonucleoprotein K, transcript variant X8
heterogeneous nuclear ribonucleoprotein K, transcript variant X3
heterogeneous nuclear ribonucleoprotein K, transcript variant X5
heterogeneous nuclear ribonucleoprotein K, transcript variant X1
heterogeneous nuclear ribonucleoprotein K, transcript variant X6
heterogeneous nuclear ribonucleoprotein K, transcript variant X4
heterogeneous nuclear ribonucleoprotein K, transcript variant X2
heterogeneous nuclear ribonucleoprotein K, transcript variant X9
heterogeneous nuclear ribonucleoprotein K, transcript variant X7
heterogeneous nuclear ribonucleoprotein K isoform X1
heterogeneous nuclear ribonucleoprotein K isoform X2
cytochrome b5-like, transcript variant X1
cytochrome b5-like, transcript variant X2
pupal cuticle protein 20-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pupal cuticle protein 20-like, transcript variant X1
pupal cuticle protein 20-like isoform X1
pupal cuticle protein 20-like isoform X2
phospholipid-transporting ATPase ABCA1-like, transcript variant X1
phospholipid-transporting ATPase ABCA1-like, transcript variant X3
phospholipid-transporting ATPase ABCA1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
phospholipid-transporting ATPase ABCA1-like
transforming acidic coiled-coil-containing protein 3, transcript variant X1
transforming acidic coiled-coil-containing protein 3, transcript variant X3
transforming acidic coiled-coil-containing protein 3, transcript variant X2
transforming acidic coiled-coil-containing protein 3 isoform X1
transforming acidic coiled-coil-containing protein 3 isoform X3
transforming acidic coiled-coil-containing protein 3 isoform X2
uncharacterized LOC124425791, transcript variant X2
uncharacterized LOC124425791, transcript variant X1
protein limb expression 1 homolog, transcript variant X3
protein limb expression 1 homolog, transcript variant X1
protein limb expression 1 homolog, transcript variant X2
protein limb expression 1 homolog isoform X1
protein limb expression 1 homolog isoform X2
ATP-dependent Clp protease proteolytic subunit
transmembrane protein 223, transcript variant X2
transmembrane protein 223, transcript variant X3
transmembrane protein 223, transcript variant X1
uncharacterized protein LOC124425479 isoform X3
uncharacterized protein LOC124425479 isoform X2
uncharacterized LOC124425478, transcript variant X1
uncharacterized LOC124425478, transcript variant X2
uncharacterized protein LOC124425478 isoform X2
uncharacterized protein LOC124425478 isoform X1
Sjoegren syndrome nuclear autoantigen 1 homolog
maternal protein tudor-like, transcript variant X3
maternal protein tudor-like, transcript variant X1
maternal protein tudor-like, transcript variant X4
maternal protein tudor-like, transcript variant X2
E3 ubiquitin-protein ligase RNF146, transcript variant X1
E3 ubiquitin-protein ligase RNF146, transcript variant X2
E3 ubiquitin-protein ligase RNF146 isoform X1
E3 ubiquitin-protein ligase RNF146 isoform X2